This page is designed to help you find out whether HEKMA is good and if it is the right choice for you.
HEKMA is an AI-powered clinical trial intelligence company focused on accelerating clinical research by improving patient recruitment, trial feasibility, and patient engagement. The company serves CROs, pharmaceutical sponsors, hospitals, and patients through an integrated platform that connects electronic health records (EHRs), AI-driven trial matching, clinical trial management, and patient engagement tools. Its mission is to reduce enrollment delays, improve access to clinical trials; particularly for underserved populations and make clinical research more efficient, transparent, and patient-centric. HEKMA combines expertise in healthcare, artificial intelligence, and clinical operations while maintaining compliance with industry standards such as HIPAA, 21 CFR Part 11, GDPR, and HL7/FHIR.
Listed in
AI-Powered Automation
Hekma AI leverages artificial intelligence to automate processes, which can save users significant time and reduce manual workload compared to traditional methods.
Modern Interface
The platform appears to offer a clean, modern user interface that is designed to be intuitive and accessible for users with varying levels of technical expertise.
Scalability
Being a cloud-based AI solution, Hekma AI likely offers scalability, allowing businesses to expand their usage as their needs grow without significant infrastructure changes.
Specialized Use Case Focus
Hekma AI seems to target specific use cases, which can mean the tool is well-optimized and tailored for particular workflows rather than being a generic solution.
Potential for Integration
Modern AI platforms like Hekma AI often provide integration capabilities with other tools and systems, making it easier to fit into existing tech stacks.
HEKMA was born from a simple, painful observation: patients and caregivers searching for the next option, often a clinical trial, when standard treatment runs out, lose critical time not to the disease itself, but to a broken system. Families spend months piecing together eligibility criteria, chasing down trial coordinators, and hoping to find the right study before it's too late. HEKMA's founders set out to compress that search from years to days, building an AI-driven platform that meets patients and caregivers where they are and connects them to life-changing research faster than the traditional referral pathway ever could.
We just have Rocket Trials as the biggest customer now!
HEKMA is a patient-centric AI platform built by doctors, AI specialists, and enterprise solution architects, connecting underrepresented populations to clinical trials and generating new revenue streams for clinics and hospitals. Its differentiator is running both directions at once: matching a patient's profile against every eligible trial while also making that patient discoverable to study teams searching for participants like them. It also stays engaged post-enrollment with a live study feed that gives phase-by-phase transparency and plain-English updates from the study team, addressing the gap where most trial participants never learn their study's outcome.
Three segments, per HEKMA's own site structure: (1) patients with serious/chronic/rare conditions seeking trials, (2) trial sponsors and CROs seeking diverse recruitment, and (3) patient advocacy groups (PAGs), given a dedicated workspace to manage and engage their communities, plus hospitals/sponsors directly (the platform serves patients, PAGs, sponsors, CROs, and research sites).
Most trial-matching tools stop at "here's a list of trials." HEKMA's edge is the full lifecycle: an AI-organized health record pulled from connected EHRs, weekly AI trial matching in plain English, an appointment hub, medication adherence tracking shared with study teams only by consent, and connected wearable/device data stored as FHIR R4 observations. For hospitals and sponsors specifically, the pitch is unlocking diverse, underrepresented patient populations and turning innovation labs into commercial profit centers, addressing well-documented enrollment gaps.
Machine-driven intelligence built from EHR and patient-generated data, standardized to FHIR R4 observations, with integrations across Apple Watch, Apple Health, Google Health Connect and more . Compliance/security stack: HIPAA, GDPR, SOC 2 Type II, ISO 27001, UAE PDPL, 21 CFR Part 11, and ICH GCP E6(R3).
We have collected here some useful links to help you find out if HEKMA is good.
Check the traffic stats of HEKMA on SimilarWeb. The key metrics to look for are: monthly visits, average visit duration, pages per visit, and traffic by country. Moreoever, check the traffic sources. For example "Direct" traffic is a good sign.
Check the "Domain Rating" of HEKMA on Ahrefs. The domain rating is a measure of the strength of a website's backlink profile on a scale from 0 to 100. It shows the strength of HEKMA's backlink profile compared to the other websites. In most cases a domain rating of 60+ is considered good and 70+ is considered very good.
Check the "Domain Authority" of HEKMA on MOZ. A website's domain authority (DA) is a search engine ranking score that predicts how well a website will rank on search engine result pages (SERPs). It is based on a 100-point logarithmic scale, with higher scores corresponding to a greater likelihood of ranking. This is another useful metric to check if a website is good.
The latest comments about HEKMA on Reddit. This can help you find out how popualr the product is and what people think about it.
Do you know an article comparing HEKMA to other products?
Suggest a link to a post with product alternatives.
Is HEKMA good? This is an informative page that will help you find out. Moreover, you can review and discuss HEKMA here. The primary details have been verified within the last quarter. So they could be considered up to date. If you think we are missing something, please use the means on this page to comment or suggest changes. All reviews and comments are highly encouranged and appreciated as they help everyone in the community to make an informed choice. Please always be kind and objective when evaluating a product and sharing your opinion.
